查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球間歇性導管市場
市場調查報告書
商品編碼
1140740

2022-2029 年全球間歇性導管市場

Global Intermittent Catheter Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 170 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

尿失禁的增加正在推動市場增長

無心漏尿稱為尿失禁。它是由尿道括約肌的喪失或無力引起的。它可能與壓力源一起發生，例如在懷孕期間和之後的咳嗽，並且在肥胖等情況下更為常見。根據美國泌尿外科協會的報告，美國四分之一到三分之一的男性和女性患有尿失禁。大約 3300 萬人患有膀胱過度活動症 (OAB)，伴有或不伴有尿急、尿頻和急迫性尿失禁。 OAB 是一種尿失禁，也稱為“急迫性”尿失禁。 OAB 影響著美國 30% 以上的男性和 40% 的女性，並影響著人們的生活。國家醫學圖書館報告說，女性比男性更常見尿失禁。美國有 24% 到 45% 的女性報告有一定程度的尿失禁。 7% 到 37% 的 20 到 39 歲的女性抱怨有一定程度的尿失禁。在美國，據說國際上約有 1300 萬人受到尿失禁的影響。隨著人年齡的增長，這種疾病變得更有可能發生。因此，老年人口的增加也將加速市場增長。

此外，對間歇性導尿管的需求增加將很快推動間歇性導尿管行業的增長，因為與其他商品相比，這些設備更易於操作且導尿成本更低。預計。此外，預計全球尿失禁患者數量的增加和老年人口的增加將推動預測期內的市場增長。

但是，與間歇性導管相關的風險阻礙了市場增長。頻繁使用間歇性導尿管會帶來潛在風險，例如尿路感染 (UTI)。其他風險包括尿道狹窄、尿道炎、尿道出血、膀胱結石和生殖器感染。與使用間歇性導管相關的並發症是預計在預測期內抑制全球市場增長的關鍵因素。

地理滲透率

北美地區有望主導全球間歇導管市場

該研究按地區分析了全球市場的間歇性導管市場，包括北美、歐洲、亞太地區、南美、中東和非洲。

到 2021 年，北美在全球間歇性導管市場中佔有壓倒性的份額。預計美國在預測期內將代表北美的大幅增長。該國醫療基礎設施完善，人均醫療費用高，導致間歇性導管市場巨大。預計對研發和先進產品開發的大量投資將推動整個地區的市場增長。

由於人口眾多，主要在印度和中國，預計亞太地區的間歇性導管市場將在預測期內快速增長。此外，預計醫療保健成本上升和各種泌尿系統疾病患病率激增將推動亞太地區間歇性導管市場的增長。

競爭格局

由於主要醫療公司的存在，間歇性導管市場是一個競爭激烈的市場。為全球市場增長做出貢獻的一些領先的間歇性導管製造商包括： Braun Melsungen AG、ConvaTec Healthcare B S.a.r.l、Coloplast Ltd.、Cook Medical、Teleflex Incorporated、Medline Industries Inc、Medtronic、C.R. Bard Inc、Adapta Medical、Becton Dickson Company 等。主要參與者正在為間歇性導管市場的全球增長採用新型的啟動和擴展策略。 2022年3月，全球醫療產品及科技公司康威達集團完成對Triad Life Sciences Inc.的收購。收購的重點是專注-創新-簡化-構建-執行戰略，以加強 Convatec 在美國的 AWC 地位（重點）和補充和創新技術平台，以增強先進的傷口管理和患者結果有助於確保獲得（創新） 2022 年 6 月，全球領先的醫療技術提供商 Teleflex 在澳大利亞和新西蘭推出了新的 Arrow 壓力注射中線導管。該產品旨在增強中線產品組合，以滿足臨床醫生不斷擴大的需求並提高患者安全性。這種新的 20 厘米箭頭壓力可注射中線帶有亮黃色的轂和標籤，可幫助臨床醫生剋服導管識別的困惑，這可能導致可能傷害患者的注射錯誤。它有 1 流明和 2 流明配置。 2022 年 2 月，全球領先的醫療技術公司 Teleflex 獲得了 FDA 的擴大適應症批准，用於在穿越慢性全閉塞經皮冠狀動脈介入治療 (CTO PCI) 程序中使用專用導管和冠狀動脈導絲。 2021 年 2 月，Teleflex, Inc. 完成了對領先止血器製造商 Z-Medica LLC 的收購。 Z-Medica 專注於創新出血控制產品的銷售和營銷。

COVID-19 的影響預測全球間歇性導管市場將穩定增長。

由於非 COVID-19 相關的醫療保健設施以正常速度運行，預計全球對間歇性導管的需求增長將在整個 COVID-19 流行期間保持穩定。在當前的 COVID-19 大流行之後，間歇性導管市場預計將保持穩定。市場進入者必須專注於解決 COVID-19 大流行帶來的供應鏈挑戰並設計適當的解決方案。

全球間歇性導管市場報告包括大約 61 個市場數據表、53 個圖表和 170 頁

內容

第 1 章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按類型劃分的市場細分
  • 按指標劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
    • 促進因素
      • 尿失禁增加
      • 不斷增長的老年人口
    • 抑制因素
      • 與間歇性使用導管相關的風險
    • 影響分析

第 5 章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST 分析
  • 定價分析
  • 監管分析
  • 保險報銷分析
  • 未滿足的需求
  • 專利趨勢

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按類型

  • 無塗層
  • 塗層
  • 含潤滑劑

第 8 章適應症

  • 尿失禁
  • 普通外科
  • 脊髓損傷
  • 其他

第 9 章最終用戶

  • 醫院
  • 醫學研究所
  • 門診手術中心

第 10 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第 12 章公司簡介

  • B.Braun Melsungen AG
    • 公司概況
    • 產品組合和內容
    • 主要亮點
    • 財務摘要
  • ConvaTec Healthcare B S.a.r.l.
  • Coloplast Ltd..
  • Cook Medical.
  • Teleflex Incorporated.
  • Medline Industries Inc.
  • Medtronic
  • C. R. Bard Inc.
  • Adapta Medical
  • Becton Dickson Company（*LIST NOT EXHAUSTIVE）

第 13 章重要注意事項

第 14 章 DataM

簡介目錄
Product Code: DMPH3139

Market Overview

Intermittent Catheter Market was valued at USD YY million in 2021. It is forecasted to reach USD YY million by 2029, growing at a CAGR of 4.1% during the forecast period (2022-2029).

An Intermittent Catheter is used in patients who are unable to do so normally to drain urine from the bladder. These catheters are meant to be used for a brief period. These are indicated for conditions like urinary leakage, incontinence, and other problems with the bladder. Neurogenic bladder diseases like spinal cord injury, multiple sclerosis, or spina bifida, as well as non-neurogenic bladder diseases, may cause urinary incontinence. The periodic catheter is placed into the urethra, and urine is gathered into the collection bag with the help of the catheter hose. A catheter should be removed after emptying the bladder. The growth of the global market for intermittent catheters is projected to rely on popularity due to a lower risk of CAUTI (catheter-acquired urinary tract infection) and the advent of more effective, less invasive, and newer catheters.

Market Dynamics: The rise in prevalence of urinary incontinence drives market growth

The unintentional leakage of urine is urinary incontinence. The urinary sphincter's power is either lost or diminished. It can arise due to stress factors such as coughing during and after gestation and is more frequent in conditions such as obesity. According to the American Urology Association report, a quarter to a third of men and women in the U.S. suffer from urinary incontinence. About 33 million have overactive bladder (OAB), representing symptoms of urgency, frequency and with or without urge incontinence. OAB is a type of urinary incontinence, also called "urgency" incontinence. OAB affects more than 30% of men and 40% of women in the U.S. It affects people's lives. According to the National library of medicine report, women's urinary incontinence is more frequent than men's. In America, 24% to 45% of women report some degree of urinary incontinence. 7% to 37% of women ages 20 to 39 report some degree of urinary incontinence. In addition, approximately 13 million people are internationally affected by urinary incontinence in America. The chances of the disease increase with the age of human beings. Thus, the increase in the older population also accelerates the market growth.

Also, the increased demand for intermittent urinary catheters is expected to fuel the growth of the intermittent catheter industry shortly because, relative to other goods, these instruments provide greater ease of handling and low catheterization costs. Furthermore, the rise in urinary incontinence cases and the increase in the geriatric population globally are anticipated to drive market growth during the forecast period.

However, risks associated with intermittent catheters hamper the market growth. The frequent use of intermittent catheters leads to potential risks such as urinary tract infections (UTI). Other risks include urethral stricture, urethritis, urethral bleeding, bladder stones and genital infection. The complications associated with the use of intermittent catheters are a key factor expected to curtail the growth of the global market over the forecast period.

Market Segmentation: The non-Coated segment is projected to be the dominant segment in the market during the forecast period.

Based on the type, the intermittent catheter market has been classified into non-coated, coated and pre-lubricated.

Non-Coated dominated the global market in 2021, owing to the wide usage of Non coated owing to the modern Indications used in the manufacturing of Non-Coated, which reduces allergies associated with latex indications, whereas coated is expected to present considerable growth in the near future. As a consequence of the adoption of intermittent antimicrobial catheters, that helps to mitigate infections induced by catheterization.

The global intermittent catheter market is segmented based on end-user, which includes hospitals and medical research centers and ambulatory surgery centers.

Hospitals held a significant market share in the global market during the forecast period as the majority of the urinary incontinence and urinary infection cases are brought directly into the hospitals for treatment, which supports the segment growth during the forecast period. Moreover, the Medical Research Centers is expected to project a considerable CAGR during the forecast period. Increasing research and product development investments are expected to propel the segment's growth in the near future.

Geographical Penetration: North America region is expected to dominate the global intermittent catheter market

Based on geography, the study analyzes the Intermittent Catheter market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America is dominant in the global intermittent catheter market in 2021. The U.S. is expected to represent considerable growth in North America during the forecast period. The country's well-established healthcare infrastructure and high healthcare expenditure per capita result in a huge market for Intermittent Catheters. Significant investment in R&D and advanced product development is expected to propel the market growth across the region.

The intermittent catheter market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the large population base, especially in India and China. Moreover, the rise in health care expenditure and the rapidly increasing prevalence of various urologic diseases are expected to augment the growth of the Asia Pacific intermittent catheter market.

Competitive Landscape:

The intermittent catheter market is highly competitive, owing to the presence of big medical companies. The key Intermittent Catheter players contributing to the growth of the global market include. Braun Melsungen AG, ConvaTec Healthcare B S.a.r.l, Coloplast Ltd.., Cook Medical., Teleflex Incorporated., Medline Industries Inc., Medtronic, C. R. Bard Inc, Adapta Medical, Becton Dickson Company, among others. The major players are adopting new Type launch and expansion strategies for global growth in the Intermittent Catheter market. In March 2022, Convatec Group, global medical products and technologies company completed the acquisition of Triad Life Sciences Inc. This acquisition focused on the Focus-Innovate-Simplify-Build-Execute strategy and helped to strengthen Convatec's AWC position in the US (Focus) and to secure access to a complementary and innovative technology platform (Innovation) that enhances advanced wound management and patient outcomes. In June 2022, Teleflex, a leading global provider of medical technologies, launched a new Arrow Pressure Injectable Midline Catheter in Australia and New Zealand. It enhances the Midline portfolio to meet the expanded needs of clinicians and is designed to improve patient safety. This new 20 cm Arrow Pressure Injectable Midline with brightly colored yellow hubs and labeling help clinicians overcome catheter identification confusion, which can lead to infusion mistakes that can harm patients. It is available in 1-lumen and 2-lumen configurations. In February 2022, Teleflex, a leading global provider of medical technologies, received FDA approval for Expanded Indication for specialty catheter and coronary guidewire use in crossing chronic total occlusion percutaneous coronary interventions (CTO PCI) Procedures. In February 2021, Teleflex Inc. completed the acquisition of Z-Medica LLC, an industry-leading manufacturer of hemostatic products. Z-Medica focused on the sales and marketing of innovative hemorrhage control products.

COVID-19 Impact: Steady growth of the global intermittent catheter market.

The growth of the global demand for intermittent catheters is projected to stay stable throughout the emergence of the COVID-19 pandemic, as non-COVID-related healthcare facilities continue to run at a regular pace. The market for Intermittent Catheters is expected to stay stable in the wake of the current COVID-19 pandemic. Market participants must concentrate on solving the supply chain issues raised by the COVID-19 pandemic and designing appropriate solutions to resolve them.

The global intermittent catheter market report would provide an access to approximately 61 market data tables, 53 figures and 170 pages

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Indication
  • 3.3. Market Snippet by End User
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in Urinary Incontinence
      • 4.1.1.2. Increasing geriatric Population
    • 4.1.2. Restraints:
      • 4.1.2.1. Risks associated with the use of intermittent catheters
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
  • 7.3. Market Attractiveness Index, By Type Segment
    • 7.3.1. Non-Coated*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Coated
    • 7.3.3. Pre-Lubricated

8. By Indication

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication Segment
  • 8.3. Market Attractiveness Index, By Indication Segment
    • 8.3.1. Urinary Incontinence*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. General Surgery
    • 8.3.3. Spinal Injuries
    • 8.3.4. Others

9. By End User

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
  • 9.3. Market Attractiveness Index, By End User Segment
    • 9.3.1. Hospitals*
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. Medical research centers
    • 9.3.3. Ambulatory Surgery Centers

10. By Region

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 10.3. Market Attractiveness Index, By Region
  • 10.4. North America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. U.S.
      • 10.4.6.2. Canada
      • 10.4.6.3. Mexico
  • 10.5. Europe
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. Germany
      • 10.5.6.2. U.K.
      • 10.5.6.3. France
      • 10.5.6.4. Italy
      • 10.5.6.5. Spain
      • 10.5.6.6. Rest of Europe
  • 10.6. South America
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.6.6.1. Brazil
      • 10.6.6.2. Argentina
      • 10.6.6.3. Rest of South America
  • 10.7. Asia Pacific
    • 10.7.1. Introduction
    • 10.7.2. Key Region-Specific Dynamics
    • 10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.7.6.1. China
      • 10.7.6.2. India
      • 10.7.6.3. Japan
      • 10.7.6.4. Australia
      • 10.7.6.5. Rest of Asia Pacific
  • 10.8. Middle East and Africa
    • 10.8.1. Introduction
    • 10.8.2. Key Region-Specific Dynamics
    • 10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. B. Braun Melsungen AG*
    • 12.1.1. Company Overview
    • 12.1.2. Type Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. ConvaTec Healthcare B S.a.r.l.
  • 12.3. Coloplast Ltd..
  • 12.4. Cook Medical.
  • 12.5. Teleflex Incorporated.
  • 12.6. Medline Industries Inc.
  • 12.7. Medtronic
  • 12.8. C. R. Bard Inc.
  • 12.9. Adapta Medical
  • 12.10. Becton Dickson Company(*LIST NOT EXHAUSTIVE)

13. Premium Insights

14. DataM Intelligence

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us